✦ LIBER ✦

New strategies to overcome limitations of reversible EGFR tyrosine kinase inhibitor therapy in non-small cell lung cancer

✍ Scribed by Doebele, Robert C.; Oton, Ana B.; Peled, Nir; Camidge, D. Ross; Bunn, Paul A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

New CT response criteria in non-small ce

✍ Lee, Ho Yun; Lee, Kyung Soo; Ahn, Myung-Ju; Hwang, Hye Sun; Lee, Ju Won; Park, K 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 819 KB

Volumetric tumor growth in advanced non-

✍ Nishino, Mizuki; Dahlberg, Suzanne E.; Cardarella, Stephanie; Jackman, David M.; 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 311 KB

Activating and resistance mutations of E

✍ Gazdar, A F 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 213 KB

The Potential Clinical and Economic Outc

✍ Josh J. Carlson; Louis P. Garrison; Scott D. Ramsey; David L. Veenstra 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB

Subsequent chemotherapy reverses acquire

✍ Renhua Guo; Xiaofen Chen; Tongshan Wang; Zhiyuan Zhang; Jin Sun; Yongqian Shu 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 307 KB

Combining an EGFR directed tyrosine kina

✍ Yaara Gorzalczany; Yuval Gilad; Dina Amihai; Ilan Hammel; Ronit Sagi-Eisenberg; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 784 KB